Compound information
- Natural Products
- ZC848120
- Molecular Formula
- C13H17NO4
- Molecular Weight
- 251.115758024 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-(benzyloxycarbonylamino)pentanoic acid
- InChI
- InChI=1S/C13H17NO4/c1-2-6-11(12(15)16)14-13(17)18-9-10-7-4-3-5-8-10/h3-5,7-8,11H,2,6,9H2,1H3,(H,14,17)(H,15,16)/t11-/m1/s1
- InChI Key
- NSJDRLWFFAWSFP-LLVKDONJSA-N
- SMILES
- CCC[C@@H](NC(=O)OCc1ccccc1)C(=O)O
- Source
- ZINC000002163699
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 18 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 2.364 |
LogS | -2.721 | LogD | 1.331 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.008 | Pgp substrate | 0.005 |
HIA | 0.961 | F20 % | 0.996 |
F30 % | 0.95 | Caco-2 | -4.907 |
MDCK | -5.401 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.941 | PPB | 74.311 |
VD | 0.374 | Fu | 0.673 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.004 | CYP1A2 substrate | 0.548 |
CYP2A6 substrate | 0.375 | CYP2B6 substrate | 0.465 |
CYP2C19 inhibitor | 0.028 | CYP2C19 substrate | 0.476 |
CYP2C8 substrate | 0.572 | CYP2C9 inhibitor | 0.041 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.026 |
CYP2D6 substrate | 0.182 | CYP2E1 substrate | 0.375 |
CYP3A4 inhibitor | 0.025 | CYP3A4 substrate | 0.793 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.871 | CL | 1.668 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.261 |
Mutagenicity | 0.014 | Rat Oral Acute Toxicity | 0.035 |
FDAMDD | 0.029 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.006 | Eye Corrosion | 0.003 |
Eye Irritation | 0.131 | Respiratory Toxicity | 0.004 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.144 | IGC50 | 2.238 |
LC50FM | 3.521 | LC50DM | 4.242 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.393 | NR-AR-LBD | 0.327 |
NR-AhR | 0.004 | NR-Aromatase | 0.029 |
NR-ER | 0.34 | NR-ER-LBD | 0.315 |
NR-PPAR-gamma | 0.488 | SR-ARE | 0.039 |
SR-ATAD5 | 0.266 | SR-HSE | 0.074 |
SR-MMP | 0.01 | SR-p53 | 0.026 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.